Rosetta Genomics Raises $1.75M, Negotiating for Additional $1.25M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics announced today it has raised $1.75 million in a private placement, and is negotiating for another $1.25 million.

The $1.75 million was raised through the sale of senior secured debentures to an unnamed accredited investor. The debentures have a maturity date of Jan. 26, 2013 and accrue interest at 10 percent annually, payable semi-annually.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.